1. Potential risks of pharmacy compounding;Gudeman;Drugs R D,2013
2. National Association of Pharmacy Regulatory Authorities (NAPRA) . Model standards for pharmacy compounding of hazardous sterile preparation, 2019. Available: https://napra.ca/sites/default/files/2017-09/Mdl_Stnds_Pharmacy_Compounding_Hazardous_Sterile_Preparations_Nov2016_Revised_b.pdf [Accessed 4 Apr 2019].
3. United states Pharmacopeial Convention (USP) . <797> pharmaceutical compounding-Sterile preparations, 2019. Available: https://www.sefh.es/fichadjuntos/USP797GC.pdf [Accessed 4 Apr 2019].
4. Ordre des pharmaciens du Québec . Préparation de produits stériles non dangereux en pharmacie. Norme 2014.01. Tableau 9, 2019. Available: https://www.opq.org/doc/media/1827_38_fr-ca_0_norme201401_prod_steriles_non_dang_oct2017.pdf [Accessed 4 Apr 2019].
5. Evaluation of microbial growth in select inoculated antineoplastic solutions;Briceland;Hosp Pharm,1990